1Stewart C,Ann L,Erickson,et al.Analysis of a Successful Immune Response against Hepatitis C Virus[J].Immunity,1999,10(4):439-449.
2Appay V.et al.Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections[J].Nat Med,2002,8(4):379-385.
3Khakoo SI,Thio CL,Martin MP,et al.HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection[J].Science,2004,305(5685):872-874.
4Morishima C,Paschal DM,Wang CC,et al.Decreased NK cell frequency in chronic hepatitis C doesnot affect ex vivo cytolytic killing[J].Hepatology,2006.43(3):573-580.
5Herzer K,Falk CS,Encke J,et al.Upregulation of major histocompatibility complex class Ⅰ on liver cells by hepatitis C viruscore protein via p53 and TAP1 impairs natural killer cell cytotoxicity[J].J Virol,2003,77(15):8299-8309.
6Moretta L.and Moretta A.Unravelling natural killer cell function:triggering and inhibitory human NK receptors[J].EMBO J.2004,23(2):255-259.
7Nattermann J,Nischalke H,Hofmeister V,et al.The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells[J].Am J Pathol,2005,166(2):443-453.
8JinushiM,Takehara T,Tatsumi T,et al.Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection[J].J Immunol,2004,173(10):6072-6081.
9Radaeva S,Sun R,Jarugga B,et al.Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners[J].Gastroenterology,2006,130(2):435-452.
10Sharma S,tenever BR,Grandvaux N,et al.Triggering the interferon antiviral response through a novel IKK-related pathway[J].Science,2003,300(5622):1148-1151.
8Gal-Tanamy M,Bachmetov L,Ravid A. Vitamin D:an innate antiviral agent suppressing hepatitis C virus in human hepato-cytes[J].HEPATOLOGY,2011,(05):1570-1579.
9Lee SS,Heathcote EJ,Reddy KR,et al.Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a(40 KD)[J].J Hepatol,2002,37(4):500-506.
10Lagging M,Langeland N,Pedersen C,et al.Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection[J].Hepatology,2008,47(6):1837-1845.
